Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Embracing Future HoldingsSGX:8YY -7.14% Days Payable is 16.03 as of Dec. 2025, which is 84% below its 10-year median of 102.65. The stock has 5 warning signs investors should review. Among 190 Medical Diagnostics & Research companies, Embracing Future Holdings ranks worse than 56.84% on this metric.
The historical rank and industry rank for Embracing Future Holdings's Days Payable or its related term are showing as below:
SGX:8YY'
s Days Payable Range Over the Past 10 Years
Min: 22.23 Med: 102.65 Max: 527.27
Current: 53.96
During the past 11 years, Embracing Future Holdings's highest Days Payable was 527.27. The lowest was 22.23. And the median was 102.65.
SGX:8YY's Days Payable is ranked worse than 56.84% of 190
companies
in the Medical Diagnostics & Research industry
Industry Median: 64.64
vs SGX:8YY: 53.96
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SGX:8YY vs TMO, DHR, IDXX: Days Payable Comparison
For the Diagnostics & Research subindustry, Embracing Future Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Embracing Future Holdings Days Payable vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Embracing Future Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where Embracing Future Holdings's Days Payable falls into.
Embracing Future Holdings Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Embracing Future Holdings's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Embracing Future Holdings (SGX:8YY) has a Days Payable of 16.03 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Embracing Future Holdings and its competitors. This is 84% below median its historical median of 102.65. Over the past decade, Embracing Future Holdings' Days Payable has ranged from 22.23 to 527.27. According to the industry distribution chart, Embracing Future Holdings ranks #108 out of 190 companies in the Medical Diagnostics & Research industry, placing it in the top 56.8%.
Is Embracing Future Holdings' Days Payable too high?
Embracing Future Holdings' current Days Payable of 16.03 is 84% below median its 10-year median of 102.65. Over the past 10 years, this metric has ranged from a low of 22.23 to a high of 527.27. The Medical Diagnostics & Research industry median Days Payable is 64.64. Embracing Future Holdings' value of 16.03 is 75.2% below this industry median. Based on the distribution chart, Embracing Future Holdings ranks #108 out of 190 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint.
How does Embracing Future Holdings' Days Payable compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Embracing Future Holdings ranks #108 out of 190 companies for Days Payable. This places Embracing Future Holdings in the lower half of its industry. The industry median Days Payable is 64.64. Embracing Future Holdings' value of 16.03 is 75.2% below this benchmark. Historically, Embracing Future Holdings' own Days Payable has ranged from 22.23 to 527.27 over the past decade. While the company's 10-year median is 102.65 vs. the industry median of 64.64, Embracing Future Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 64.64, based on 190 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Embracing Future Holdings's current Days Payable of 16.03 is 75.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Embracing Future Holdings and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 64.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Embracing Future Holdings's current Days Payable is 16.03, which is 84% below median its own 10-year median of 102.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embracing Future Holdings stock overvalued right now?
Embracing Future Holdings (SGX:8YY) has a current Days Payable of 16.03. The current Days Payable is 16.03, which is 84% below median its 10-year median of 102.65 and 75.2% below the Medical Diagnostics & Research industry median of 64.64. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Embracing Future Holdings (SGX:8YY), the current Days Payable is 16.03 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Embracing Future Holdings Ltd is engaged in technology development, technology transfer, marketing, sales, and distribution of biomedical technology, life, and medicine science-related products and services, and investment holding. The company's business segments are: Cancer, Infectious Diseases, E-sports, Advertising, and Corporate. The company generates the majority of its revenue from the E-sports segment, which involves identifying and assessing potential collaboration partners, technology, digital platforms, products, and services related to E-Sports. Its operations are spread across Singapore, Japan, China, Europe, Hong Kong, Thailand, Malaysia, and other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:8YY has been successfully added to your 
